| scholarly article | Q13442814 |
| case report | Q2782326 |
| P50 | author | Maurizio Pompili | Q41813401 |
| P2860 | cites work | Affective Disorders and Suicide Risk: A Reexamination | Q22306288 |
| Does Rejection Hurt? An fMRI Study of Social Exclusion | Q28208863 | ||
| Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation | Q28307938 | ||
| Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression | Q31089490 | ||
| Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study | Q34677398 | ||
| Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression | Q36801188 | ||
| The neurodevelopmental origins of suicidal behavior | Q37969386 | ||
| The communication of suicidal intentions: a meta-analysis | Q39726108 | ||
| "Clinical judgment" and the DSM-5 diagnosis of major depression | Q42156452 | ||
| Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients | Q43285437 | ||
| Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). | Q44268852 | ||
| Suicide as psychache. | Q46006726 | ||
| Poor response to antidepressants predicts new suicidal ideas and behavior in depressed outpatients | Q47326008 | ||
| Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment | Q47351642 | ||
| The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. | Q47402907 | ||
| Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial | Q47688167 | ||
| Phenomenology of manic episodes according to the presence or absence of depressive features as defined in DSM-5: Results from the IMPACT self-reported online survey | Q48368506 | ||
| When does depression become a mental disorder? | Q48820434 | ||
| Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder. | Q50633518 | ||
| Mortality in current and former users of clozapine. | Q50928138 | ||
| Vital Signs: Trends in State Suicide Rates - United States, 1999-2016 and Circumstances Contributing to Suicide - 27 States, 2015. | Q55038966 | ||
| Collaborating to prevent suicide: a clinical-research perspective | Q73715195 | ||
| Does lithium exert an independent antisuicidal effect? | Q74414858 | ||
| Suicide | Q74535198 | ||
| Mediation of the influence of childhood maltreatment on depression relapse by cortical structure: a 2-year longitudinal observational study | Q92571328 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | suicidal ideation | Q944142 |
| P304 | page(s) | 7 | |
| P577 | publication date | 2019-05-31 | |
| P1433 | published in | Annals of General Psychiatry | Q15764563 |
| P1476 | title | Critical appraisal of major depression with suicidal ideation | |
| P478 | volume | 18 |
| Q91223310 | Epidemiology of suicide: from population to single cases |
| Q95270796 | Intranasal Esketamine and Current Suicidal Ideation With Intent in Major Depression Disorder: Beat the Clock, Save a Life, Start a Strategy |
| Q91841041 | Prevalence and associated factors of mental disorders in the nationwide primary care population in Latvia: a cross-sectional study |
| Q96955155 | Prevalence of and factors associated with depression among hill tribe individuals aged 30 years and over in Thailand |
| Q90631294 | Understanding the Complex of Suicide in Depression: from Research to Clinics |
Search more.